Androgens may explain male vulnerability to COVID-19
May 8, 2020
Androgen deprivation therapy may be protective against COVID-19, a study suggests.
Antitumor treatment may increase risk of severe events in COVID-19 patients
May 1, 2020
Receiving antitumor treatment within 14 days of COVID-19 diagnosis was linked to a higher risk of ICU admission, mechanical ventilation, or death.
COVID-19 decimates outpatient visits
April 27, 2020
A study of more than 50,000 U.S. health care providers showed sharp declines in outpatient visits between March 1 and April 5.
EHA and TIF explore how COVID-19 is affecting thalassemia and SCD patients
April 20, 2020
Thalassemia patients appeared to fare relatively well after COVID-19 diagnosis in anecdotal series reports from Europe.
Can convalescent plasma treat COVID-19 patients?
April 17, 2020
How COVID-19 patients can receive convalescent plasma, who is eligible to donate, and early results of treatment.
Pandemic strains blood supply for COVID-19 and noninfected patients
April 16, 2020
“There needs to be a significant call out for people to make every effort to donate blood.”
Severe COVID-19 may lower hemoglobin levels
April 15, 2020
The authors suggest that hemoglobin values might provide a prognostic indicator of COVID-19 severity.
ASH tackles COVID-19 with hematology-related FAQ, promotes new registries
April 14, 2020
The ASH COVID-19 registries focus on patients with hematological malignancies and sickle cell disease.
First report of MM patient successfully treated for COVID-19 with tocilizumab
April 6, 2020
The patient presented with chest tightness and shortness of breath, indicating that symptoms of COVID-19 can be atypical in patients with coexisting multiple myeloma.
Case study shows CLL may mask COVID-19 infection
April 3, 2020
COVID-19 was not initially suspected, as the patient’s whole blood cell and lymphocyte counts were high because of chronic lymphocytic leukemia.